SCHEMBL800179

SCHEMBL800179

CC(=O)C(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180158 0.76
SCHEMBL14886369 0.76
SCHEMBL28508934 0.73
SCHEMBL13616780 0.73
SCHEMBL18797077 0.73
SCHEMBL28202331 0.73
Bromo Acetone SCHEMBL56383 0.72
Bromopyruvate SCHEMBL272971 0.71
SCHEMBL11949176 0.69 CA4 (0.47)
Bromo Acetone SCHEMBL28874127 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119912606-A Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof 中国石油化工股份有限公司 2025-05-02 CN claimed
EP-4568666-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Alexion Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
US-20250163078-A1 IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Shanghai Simr Biotechnology Co., Ltd. (CN) 2025-05-22 US disclosed
CN-119912606-A Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof 中国石油化工股份有限公司 2025-05-02 CN disclosed
CN-119768164-A Pharmaceutical compounds for treating complement-mediated disorders 阿雷克森制药公司 2025-04-04 CN disclosed
EP-4484433-A1 IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Shanghai Simr Biotechnology Co., Ltd. (CN) 2025-01-01 EP disclosed
CN-118546107-A 2-Thiazole aminophenol derivatives and application thereof 中国药科大学 2024-08-27 CN disclosed
CN-118496224-A Imidazopyridine heterocyclic compound with cyclin dependent kinase inhibition activity, preparation method and medical application thereof 中国医药研究开发中心有限公司 2024-08-16 CN disclosed
WO-2024067820-A1 TRICYCLIC COMPOUNDS AS CDK INHIBITORS AND METHODS OF USING SAME SHENZHEN IONOVA LIFE SCIENCE CO., LTD. (CN) 2024-04-04 WO disclosed
EP-4061815-B1 PYRIMIDONE DERIVATIVES CONTAINING TWO FUSED BICYCLIC RINGS BASF SE (DE) 2024-03-20 EP disclosed
US-5364871-A Antiulcer agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-15 US disclosed
EP-0591763-A1 Use of thioalkanediones as flavouring agents HAARMANN & REIMER GMBH (DE) 1994-04-13 EP disclosed
EP-0575614-A1 THIAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-12-29 EP disclosed
WO-1992016526-A1 THIAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-10-01 WO disclosed
EP-0417751-A2 New thiazole derivatives, processes for the preparation thereof and pharmaceutical compositon comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-03-20 EP disclosed
US-4560690-A ANTISECRETORY AGENTS, HISTAMINE H2-ANTAGONISTS PFIZER INC. (US) 1985-12-24 US disclosed
EP-0161841-A1 2-(N-substituteguanidino)-4-hetero-arylthiazole antiulcer agents PFIZER INC. (US) 1985-11-21 EP disclosed
US-4216320-A Quinoxaline bleach catalysts CIBA-GEIGY AG (CH) 1980-08-05 US disclosed
US-4145217-A DYE BLEACH CATALYST CIBA-GEIGY AG (CH) 1979-03-20 US disclosed
US-3989690-A ANTI-PARASITIC AGENTS ACTIVE AGAINST TRYPANOSOMIDAE LILLY INDUSTRIES, LTD. (EN) 1976-11-02 US disclosed